Entries by Aj Cheline

‘Just Sticky Enough’ Compound May Help Patients with Kidney Disease

By Lisa Howard February 18, 2021 Several years ago, Aijun Wang, a biomedical engineer and associate professor in the UC Davis Department of Surgery, became interested in improving arteriovenous (AV) grafts used during kidney dialysis. AV grafts are synthetic medical tubes that are surgically placed in a renal patient’s arm or leg. During dialysis, the […]

UC Davis Releases 2 New Strawberry Varieties

February 11, 2021 By Diane Nelson Red, ripe strawberries are the hallmark of spring in California. Two new varieties from the Public Strawberry Breeding Program at the University of California, Davis, will provide consumers with big, flavorful strawberries throughout fall and winter, too. “These cultivars were developed to provide high-quality fruit from late summer through the […]

Team Science: Opportunities in Neuroscience

February 12th, 10:30 AM – 11:30 AM: Presentations and Insights UC Davis Conte Center: Neuroimmune mechanisms in psychiatric disorders Mechanisms underlying the effects of maternal Infections on offspring risk for neurodevelopmental and psychiatric disorders Zoom details: https://zoom.us/j/805959373 Meeting ID: 805 959 373 Password: 901020 Presenters Cameron Carter Principal Investigator for the Conte Center Director, UC Davis […]

UC Davis Receives $3.2 Million Award to Study Age-Related Macular Degeneration

January 19, 2021 Glenn Yiu, an associate professor in the Department of Ophthalmology and Vision Science, has been awarded a five-year, $3.2 million grant from the National Institutes of Health National Eye Institute for a study on age-related macular degeneration, or AMD. Yiu and his team will be looking at factors that may contribute to […]

UC Davis Licenses Novel COVID-19 Lung Treatment Using Inhaled Statins to InVixa, Inc

The University of California, Davis and InVixa Inc., a biopharmaceutical startup, have executed a licensing agreement for a novel method using inhaled statins to treat the severe respiratory disease known as COVID-19. The license, negotiated by the InnovationAccess team within the UC Davis Office of Research, provides exclusive access for InVixa to commercialize the technology […]

Update on COVID-19 Research Operations on Campus

1/12/2021 Campus leadership recently announced plans for a return to primarily in-person instruction starting fall 2021 while remaining vigilant in all critical prevention efforts and continuing to prioritize the health and well-being of the university community. We are expecting that all on-campus research activities, core facilities and research laboratories will return to full occupancy by the […]